DE1518793C - Process for the production of alkali salts of phosphocreatine excretion from 1260472 - Google Patents
Process for the production of alkali salts of phosphocreatine excretion from 1260472Info
- Publication number
- DE1518793C DE1518793C DE19591518793 DE1518793A DE1518793C DE 1518793 C DE1518793 C DE 1518793C DE 19591518793 DE19591518793 DE 19591518793 DE 1518793 A DE1518793 A DE 1518793A DE 1518793 C DE1518793 C DE 1518793C
- Authority
- DE
- Germany
- Prior art keywords
- parts
- alkali
- sodium
- phosphocreatine
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N Phosphocreatine Chemical class OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 title claims description 13
- 229950007002 phosphocreatine Drugs 0.000 title claims description 13
- 150000001447 alkali salts Chemical class 0.000 title claims description 9
- 238000000034 method Methods 0.000 title claims description 9
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 230000036826 Excretion Effects 0.000 title 1
- 230000029142 excretion Effects 0.000 title 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000011734 sodium Substances 0.000 claims description 11
- -1 dibenzyloxyphosphoryl creatine Chemical compound 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 7
- HIPLEPXPNLWKCQ-UHFFFAOYSA-N Phosphocreatinine Chemical class CN1CC(=O)N=C1NP(O)(O)=O HIPLEPXPNLWKCQ-UHFFFAOYSA-N 0.000 claims description 6
- 239000003054 catalyst Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 229940109239 Creatinine Drugs 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 159000000000 sodium salts Chemical class 0.000 claims description 3
- 238000003776 cleavage reaction Methods 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 150000004687 hexahydrates Chemical class 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 150000004685 tetrahydrates Chemical class 0.000 claims description 2
- 238000007327 hydrogenolysis reaction Methods 0.000 claims 7
- 235000019441 ethanol Nutrition 0.000 claims 6
- 239000003513 alkali Substances 0.000 claims 5
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims 4
- 229910052708 sodium Inorganic materials 0.000 claims 4
- 239000000126 substance Substances 0.000 claims 4
- 229960003624 Creatine Drugs 0.000 claims 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 3
- 230000001476 alcoholic Effects 0.000 claims 3
- 239000006046 creatine Substances 0.000 claims 3
- 125000004494 ethyl ester group Chemical group 0.000 claims 3
- 229910052763 palladium Inorganic materials 0.000 claims 3
- 239000011780 sodium chloride Substances 0.000 claims 3
- 238000001816 cooling Methods 0.000 claims 2
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical compound C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 claims 2
- 238000010438 heat treatment Methods 0.000 claims 2
- UKWHYYKOEPRTIC-UHFFFAOYSA-N mercury(II) oxide Inorganic materials [Hg]=O UKWHYYKOEPRTIC-UHFFFAOYSA-N 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 2
- 238000007363 ring formation reaction Methods 0.000 claims 2
- 238000000926 separation method Methods 0.000 claims 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 239000007858 starting material Substances 0.000 claims 2
- WGFPKVYOZXLIPN-UHFFFAOYSA-L 2-imino-1-methyl-3-phosphonatoimidazolidin-4-one Chemical compound CN1CC(=O)N(P([O-])([O-])=O)C1=N WGFPKVYOZXLIPN-UHFFFAOYSA-L 0.000 claims 1
- QWUWMCYKGHVNAV-UHFFFAOYSA-N Bibenzyl Chemical group C=1C=CC=CC=1CCC1=CC=CC=C1 QWUWMCYKGHVNAV-UHFFFAOYSA-N 0.000 claims 1
- 230000036740 Metabolism Effects 0.000 claims 1
- 210000003205 Muscles Anatomy 0.000 claims 1
- 241001474977 Palla Species 0.000 claims 1
- 238000007792 addition Methods 0.000 claims 1
- 229910052783 alkali metal Inorganic materials 0.000 claims 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
- 238000009835 boiling Methods 0.000 claims 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine zwitterion Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims 1
- NIDZUMSLERGAON-UHFFFAOYSA-N ethyl 2-(methylamino)acetate;hydron;chloride Chemical compound Cl.CCOC(=O)CNC NIDZUMSLERGAON-UHFFFAOYSA-N 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxyl anion Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims 1
- 239000012535 impurity Substances 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims 1
- 229910052753 mercury Inorganic materials 0.000 claims 1
- 230000004060 metabolic process Effects 0.000 claims 1
- 230000035786 metabolism Effects 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 235000021317 phosphate Nutrition 0.000 claims 1
- OAICVXFJPJFONN-UHFFFAOYSA-N phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 239000002244 precipitate Substances 0.000 claims 1
- 239000011541 reaction mixture Substances 0.000 claims 1
- 238000010992 reflux Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 238000007127 saponification reaction Methods 0.000 claims 1
- 239000001187 sodium carbonate Substances 0.000 claims 1
- 229910000029 sodium carbonate Inorganic materials 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 230000000007 visual effect Effects 0.000 claims 1
- 238000004458 analytical method Methods 0.000 description 5
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 3
- 230000036514 plasma sodium concentration Effects 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000000954 titration curve Methods 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N Phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000005712 crystallization Effects 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N hydrochloric acid Substances Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
Description
mit 50%igem Alkohol, worauf man im Ofen bei 50° C trocknet. Man erhält auf diese Weise 132 Teile Dibenzyloxyphosphorylkreatinin mit einem Schmelzpunkt von 91 bis 920C, also eine Ausbeute von 71%.with 50% alcohol, after which it is dried in the oven at 50 ° C. In this way, 132 parts of dibenzyloxyphosphoryl creatinine with a melting point of 91 to 92 ° C., that is to say a yield of 71%, are obtained.
Dieses Dibenzyloxyphosphorylkreatinin eignet sich ohne weitere Reinigung sehr gut zur Herstellung von Phosphokreatinin und schließlich Phosphokreatin.This dibenzyloxyphosphoryl creatinine is very suitable for the production of Phosphocreatinine and finally phosphocreatine.
Zur Analyse kristallisiert man das Produkt aus 70%igem Methanol um, wobei sich die Ausbeute auf 90% und der Schmelzpunkt auf 93 0C beläuft.For analysis to the product crystallized from 70% methanol in order, wherein the yield to 90% and the melting point to 93 0 C amounts.
Analyse für C18H20N3C4P:Analysis for C 18 H 20 N 3 C 4 P:
Berechnet ... C 57,90, H 5,40, N 11,25, P 8,30%; gefunden ... C 57,68, H 5,96, N 10,89, P 8,54%.Calculated ... C 57.90, H 5.40, N 11.25, P 8.30%; Found ... C 57.68, H 5.96, N 10.89, P 8.54%.
186,5 Teile Dibenzyloxyphosporylkreatinin werden aufgelöst in einem Gemisch aus 500 Raumteilen einer 2n-Natronlauge und 150 Raumteilen Alkohol. Dieser Lösung setzt man Palladiumschwarz hinzu (hergestellt durch Hydrieren eines Gemisches aus 95 Teilen Ruß, 1000 Teilen Wasser und 9,3 Teilen Palladiumchlorid), worauf man bei gewöhnlicher Temperatur und normalen Druck hydriert. 20 500 Raumteile Wasserstoff werden in 2 Stunden absorbiert.186.5 parts of dibenzyloxyphosporylcreatinine are dissolved in a mixture of 500 parts by volume of a 2N sodium hydroxide solution and 150 parts by volume of alcohol. Palladium black is added to this solution (prepared by hydrogenating a mixture of 95 parts of carbon black, 1000 parts of water and 9.3 parts of palladium chloride), whereupon hydrogenation is carried out at ordinary temperature and pressure. 20 500 parts by volume of hydrogen are absorbed in 2 hours.
b) Verfahren der Erfindungb) method of the invention
Für die Spaltung der Alkalisalze des Phosphokreatinins filtriert man die Reaktionsmasse zur Entfernung des Katalysators und wäscht dann den Filterrückstand mit 250 + 100 + 100 Teilen Wasser. Dem Filtrat setzt man 47,4 Teile Natriumhydroxyd, aufgelöst in 85 Teilen Wasser, hinzu. Man erhitzt in 10 Minuten auf 80° C. Die Lösung wird anschließend auf etwa 10°C gekühlt; man stellt deren pH-Wert in Gegenwart von Phenolphthalein mit 1182 Raumteilen η-Salzsäure auf 7,8 ein, filtriert und setzt der Lösung 9480 Teile Alkohol hinzu. Das Dinatriumsalz des Phosphokreatins scheidet sich in Form eines Öls ab. Man läßt es zum Auskristallisieren 2 oder 3 Tage bei Raumtemperatur stehen, filtriert, wäscht mit 80%igem Alkohol, dann mit absolutem Alkohol und schließlich mit Äther. Man trocknet im Vakuum bei gewöhnlicher Temperatur über P2O5 und unter einem Druck von etwa 20 mm Hg. Man erhält auf diese Weise 163 Teile Dinatrium-phosphokreatin-Hexahydrat, also in einer Ausbeute von 90%.For the cleavage of the alkali salts of phosphocreatinine, the reaction mass is filtered to remove the catalyst and the filter residue is then washed with 250 + 100 + 100 parts of water. 47.4 parts of sodium hydroxide, dissolved in 85 parts of water, are added to the filtrate. It is heated to 80 ° C. in 10 minutes. The solution is then cooled to about 10 ° C .; its pH is adjusted to 7.8 in the presence of phenolphthalein with 1182 parts by volume of η-hydrochloric acid, filtered and 9480 parts of alcohol are added to the solution. The disodium salt of phosphocreatine is deposited in the form of an oil. It is left to crystallize for 2 or 3 days at room temperature, filtered, washed with 80% alcohol, then with absolute alcohol and finally with ether. It is dried in vacuo at normal temperature over P 2 O 5 and under a pressure of about 20 mm Hg. In this way, 163 parts of disodium phosphocreatine hexahydrate are obtained, that is to say in a yield of 90%.
Dieses Phosphokreatin hat eine Titrationskurve, die mit der in der Literatur beschriebenen identisch ist.This phosphocreatine has a titration curve which is identical to that described in the literature.
Analyse für C4H8N3O5PNa2 · 6 H2O Molekulargewicht: 363Analysis for C 4 H 8 N 3 O 5 PNa 2 · 6 H 2 O Molecular weight: 363
Berechnet ... P 8,54, Na 12,67%;Calculated ... P 8.54, Na 12.67%;
gefunden ... P 8,54, Na 12,66%;found ... P 8.54, Na 12.66%;
P 8,77, Na 12,92%.P 8.77, Na 12.92%.
ίο Zur Umkristallisation wird das Natriumsalz des Phosphokreatins in 7 Teilen kalten Wassers aufgelöst; nach dem Filtrieren setzt man 21 Teile Alkohol hinzu und geht wie zuvor vor. Die Ausbeute bei der Umkristallisation beläuft sich auf 85%.ίο For recrystallization, the sodium salt of Phosphocreatine dissolved in 7 parts of cold water; after filtration, 21 parts of alcohol are added and proceeds as before. The recrystallization yield is 85%.
Analyse für C4H8N3O5PNa2 · 6 N2O Molekulargewicht: 363Analysis for C 4 H 8 N 3 O 5 PNa 2 · 6 N 2 O Molecular weight: 363
Berechnet: C 13,22, H 5,51, N 11,57, P 8,54,Calculated: C 13.22, H 5.51, N 11.57, P 8.54,
Na 12,67, H2O 29,75%;Na 12.67, H 2 O 29.75%;
gefunden: C 13,94, H 5,40, N 11,95, P 8,58,
Na 12,74, H2O 28,91%.found: C 13.94, H 5.40, N 11.95, P 8.58,
Na 12.74, H 2 O 28.91%.
Dieses Hexahydrat des Dinatriumsalzes des Phosphokreatins wurde unter einem Vakuum von 3 Mikron
und bei 60° C so lange getrocknet, bis das Gewicht konstant blieb; dann ließ~man es an der freien Luft
wieder bis zu einem konstanten Gewicht Wasser aufnehmen. Das Produkt enthielt dann 4 Moleküle
Kristallwasser.
30 This hexahydrate of the disodium salt of phosphocreatine was dried under a vacuum of 3 microns and at 60 ° C. until the weight remained constant; then it was allowed to take up again in the open air to a constant weight of water. The product then contained 4 molecules of water of crystallization.
30th
Analyse für C4H8N3O5PNa2 · 4 H2O, Molekulargewicht:
327
Berechnet: C 14,68, H 4,89, N 12,84, P 9,48,Analysis for C 4 H 8 N 3 O 5 PNa 2 · 4 H 2 O, molecular weight: 327
Calculated: C 14.68, H 4.89, N 12.84, P 9.48,
Na 14,07%;
gefunden: C 14,66, H 5,78, ^12,73, P 9,17,Na 14.07%;
found: C 14.66, H 5.78, ^ 12.73, P 9.17,
Na 13,61, C 14,45, H 5,68, N 12,40%.Na 13.61, C 14.45, H 5.68, N 12.40%.
Bisweilen erhält man das Tetrahydrat schon von vornherein.Sometimes the tetrahydrate is obtained from the start.
Die Titrationskurve ist identisch mit den vorhergehenden. Diese Angaben stimmen vollkommen überein mit denjenigen von A. H. E η η ο r und L. H. Stocken (Biochem. J. 43, 1948, S. 190) sowie von Peanasky und Mitarbeitern (Biochemical Preparations V, 1957, S. 9), welche geringe Mengen des Dinatriumsalzes von Phosphokreatin nach einem anderen Verfahren hergestellt haben.The titration curve is identical to the previous one. These details agree completely with those of A. H. E η η ο r and L. H. Stocken (Biochem. J. 43, 1948, p. 190) and by Peanasky and co-workers (Biochemical Preparations V, 1957, p. 9), which small amounts of the disodium salt of phosphocreatine after a other processes.
Claims (1)
ein Verfahren zur Herstellung von Dibenzyloxy- . Man erhält nach dem erfindungsgemäßen Verfahren' phosphorylkreatinin durch Verseifen des Äthylesters ein sehr reines Phosphokreatin, das von mineralischen des Dibenzyloxyphosphorylkreatins in wäßrig-alkoho- 35 Phosphaten und freiem Kreatin frei ist. Das Produkt lischem Medium mit verdünntem kaltem Natrium- kristallisiert mit 4 Molekülen Kristallwasser aus; es hydroxyd und Cyclisieren des erhaltenen Natrium- ist beständig, nicht zerfließlich und hält sich sehr gut salzes des Diesters mit äquimolaren Mengen Säure, in verschlossenen Flaschen ohne besondere Vorbezogen auf das freizusetzende Natriumhydroxyd. Sichtsmaßnahmen. .The subject of the German patent 1 260 472 is alcoholic media can carry out,
a process for the preparation of dibenzyloxy-. According to the process according to the invention, phosphoryl creatinine is obtained by saponifying the ethyl ester, a very pure phosphocreatine which is free from mineral dibenzyloxyphosphoryl creatine in aqueous alcohol phosphates and free creatine. The product medium with diluted cold sodium crystallizes with 4 molecules of crystal water; it hydroxide and cyclization of the sodium obtained is stable, does not dissolve and keeps very well salt of the diester with equimolar amounts of acid, in closed bottles without special reference to the sodium hydroxide to be released. Visual measures. .
benzyloxyphosphorylkreatinins mittels WasserstoffPhosphocreatinine by hydrogenolysis of the di- a) Production of the starting materials
benzyloxyphosphoryl creatinine using hydrogen
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR775394 | 1958-09-26 | ||
FR775394 | 1958-09-26 | ||
FR775839 | 1958-10-03 | ||
FR775839 | 1958-10-03 | ||
FR789130A FR75327E (en) | 1959-03-12 | 1959-03-12 | Process for the synthesis of phosphocreatinine |
FR789130 | 1959-03-12 | ||
DEE0030640 | 1959-09-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE1518793A1 DE1518793A1 (en) | 1969-02-20 |
DE1518793C true DE1518793C (en) | 1973-04-26 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE965036C (en) | Process for the preparation of p-(bis-2-chloroethylamino)-ª‰-phenyl-alanine | |
DE1057119B (en) | Process for the preparation of cyclic phosphoric acid ester amides | |
DE2425983C3 (en) | Sulphonic acid salts of acylcholines, processes for their preparation and pharmaceutical compositions containing them | |
DE2149070C3 (en) | Phenoxyalkylcarboxylic acid derivatives and their salts, processes for their production and pharmaceuticals | |
DE1518793C (en) | Process for the production of alkali salts of phosphocreatine excretion from 1260472 | |
DE2033357C3 (en) | Palmitoyl-propandioKl 3) -phosphoric acid-S-trimethylaminophenyl ester and process for its preparation | |
DE2004718A1 (en) | Process for the production of 4-alkylprolines and 4-alkylpyrrolines and 4-alkylpyrollidines | |
DE1518793B (en) | Process for the production of alkali salts of phosphocreatine. Elimination from: 1260472 | |
DE1545761C3 (en) | Phosphorylguanidine compounds and process for their preparation | |
DE1205094B (en) | Process for the preparation of 17alpha-aminosteroids of the androstene series | |
DE1768582C3 (en) | ||
DE930565C (en) | Process for the preparation of 1-phenyl-2-amino-1, 3-propanediols or of 1-phenyl-2-amino-1, 3-propanediols substituted in the phenyl radical | |
DE855248C (en) | Process for the preparation of aliphatic phosphoric acid ester amides | |
DE850297C (en) | Process for the preparation of amidine salts | |
DE726385C (en) | Process for the production of d-lysergic acid-1, 3-dioxytrimethylene amide- (2) | |
DE968561C (en) | Process for the preparation of monoaminoacylanilides substituted on the amino nitrogen | |
DE1178436B (en) | Process for the preparation of 2-sulfanilamido-3-methoxy-pyrazine | |
DE2033361B2 (en) | Acylpropanediol- (13) -phosphoric acid choline ester and process for their preparation | |
DE854526C (en) | Process for the production of amino alcohols | |
DE1668643C (en) | Substituted 1 benzyl 3 isopropyl carbazinate excretion from 1293148 | |
DE878656C (en) | Process for the preparation of haloacetamidodiols | |
DE1518793A1 (en) | Process for the production of phosphocreatine | |
DE3135728A1 (en) | Process for preparing apovincamine acid esters | |
DEN0008634MA (en) | ||
CH335681A (en) | Process for the preparation of new acyl derivatives of 5,6-dihydrobenzo (c) cinnoline |